Spencer Trask & Co.

Spencer Trask & Co. is a privately held advanced technology development company.

Spencer Trask & Co.
IndustryFinancial services
Headquarters,
United States
Key people
Kevin Kimberlin
(Chairman)
William Clifford
(CEO)
ServicesBuild advanced technology companies
Websitespencertraskco.com

Members and affiliates of Spencer Trask & Co. are founders of, advisors to, and investors in private and public companies through direct investments and numerous limited liability companies.

Spencer Trask & Co., has been a partner in the formative stage of genomics with Myriad Genetics,[1] healthcare reform with Health Dialog,[2] patent development with Intellectual Ventures,[3] the Internet with Ciena,[4] cloud computing infrastructure with Aperture,[5] and open innovation with InnoCentive.[6]

Legacy

The firm's namesake is Mr. Spencer A. Trask who financed Thomas Edison and was founding trustee of the predecessor to General Electric, the president of the first electricity firm, Consolidated Edison, and chairman of the New York Times.

References

  1. "Myriad: Pioneering Predictive Medicine". University of Utah, Center for Technology & Venture Commercialization. April 25, 2018.
  2. Lancaster, Hal (August 3, 1999). "Mr. George Bennett on the Founding of Health Dialog". The Wall Street Journal.
  3. Phelps, Marshall; Kline, David (2009-05-13). Burning the Ships: Transforming Your Company's Culture Through Intellectual Property Strategy. ISBN 9780470494103.
  4. Karlgaard, Richard (June 1, 1998). "Dollars from Heaven". Forbes via Forbes.com.
  5. "Spencer Trask Announces Sale of Leading Data Center Software Supplier Aperture". www.businesswire.com. March 26, 2008.
  6. Walsh, Bryan (March 10, 2008). "How Many People Does It Take to Make a New Light Bulb?" via content.time.com.

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.